What We're Reading
Industry reads hand-picked by our editors
May 17, 2024
-
Reuters
GSK raises $1.5 bln from sale of remaining Haleon stake
-
Bloomberg
Walgreens, CVS Rethink Pharmacy to Turn Around Drugstore Business
-
Nature
Could bird flu in cows lead to a human outbreak? Slow response worries scientists
-
NPR
Louisiana may reclassify drugs used in abortion as controlled dangerous substances
May 16, 2024
May 15, 2024
-
Bloomberg
Novo to Test If Obesity Drugs Can Help People Drink Less Alcohol
-
The Wall Street Journal
Flood of Fake Science Forces Multiple Journal Closures
-
In the Pipeline
AI Drugs So Far
May 14, 2024
-
FirstWord Pharma
Updated biosecurity bill would give US drugmakers until 2032 to end ties with suspect Chinese biotechs
-
Fierce Biotech
Novo Nordisk’s Hemlibra rival hits goals in Phase 3
-
Reuters
Merck stops testing combo drug for skin cancer as more patients discontinue
-
AP News
Will AI replace doctors who read X-rays, or just make them better than ever?
May 13, 2024
May 10, 2024
May 09, 2024
-
KFF Health News
Amgen Plows Ahead With Costly, Highly Toxic Cancer Dosing Despite FDA Challenge
-
Fierce Biotech
Sanofi CSO Frank Nestle is leaving
-
The Wall Street Journal
Neuralink’s First Brain-Chip Implant in a Human Appeared Flawless. There Was a Problem.